Seeking Alpha

Shares of Chembio Diagnostics (CEMI +4.2%) moves higher after the USDA approves its CervidTB...

Shares of Chembio Diagnostics (CEMI +4.2%) moves higher after the USDA approves its CervidTB STAT-PAK and DPP VetTB test kits as primary and secondary tests for bovine tuberculosis by the USDA Animal and Plant Health Inspection Service. The approval was made in order to provide the farmed deer industry with more options for meeting testing requirements for captive elk and deer.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|